Substantial Increase In Public Preference For Generic Over Brand Name Drugs
Main Category: Pharmacy / PharmacistAlso Included In: Pharma Industry / Biotech Industry
Article Date: 26 Jan 2009 - 5:00 PDT
email to a friend 
printer friendly 
opinions
| Patient / Public: |  |
4.5 (2 votes) |
| Healthcare Prof: |  |
4 (3 votes) |
| Article Opinions: | 1 posts |
The Harris Poll® finds a substantial change in the pharmaceutical drugs people buy, and how and where they buy them. In a period of just over two years, between October 2006 and December 2008, the proportion of adults who would choose generic drugs in preference to brand name prescription drugs has increased from 68% to 81%. And the number who would more often choose branded drugs has almost halved, down from 32% to only 19%.
In addition, consumers have been shopping more often for their drugs in discount stores like Wal-Mart, Target or Sam's Club (up from 13% to 17%), or shopping online or by mail order (up from 11% to 15%). Those shopping at chain drug stores like Walgreens, CVS or Eckerd are down from 39% to 33% and those using local independent pharmacies have decreased from 12% to 8%.
These are some of the results of The Harris Poll, a new nationwide survey of 2,388 U.S. adults surveyed online between December 9 and 15, 2008 by Harris Interactive®.
These trends have probably accelerated because of the economic crisis as consumers try harder to save money. However, the trend was almost certainly happening anyway. The headline for our 2006 report was "low priced generics likely to attract large share of prescription drug sales," and they have.
In line with the other findings, the amount of money people say they are willing to pay out-of-pocket for a 30-day supply of generic prescription drugs has declined since 2006. Two years ago, 56% of adults said they were willing to spend more than $10; now only 48% say they would do so.
So What?
While we predicted the increased use of low-cost generics, the size of this trend is striking. It is good news for those seeking to contain health care costs, including the government's Part D Medicare drug benefit program. It is not good news for pharmaceutical firms trying to generate the profits to fund their drug research, or for their shareholders.
Methodology
This Harris Poll® was conducted online within the United States between December 9 and 15, 2008 among 2,388 adults (aged 18 and over). Figures for age, sex, race/ethnicity, education, region and household income were weighted where necessary to bring them into line with their actual proportions in the population. Propensity score weighting was also used to adjust for respondents' propensity to be online. Full data tables and methodology are available at http://www.harrisinteractive.com.
About Harris Interactive
Harris Interactive is a global leader in custom market research. With a long and rich history in multimodal research, powered by our science and technology, we assist clients in achieving business results. Harris Interactive serves clients globally through our North American, European and Asian offices and a network of independent market research firms. For more information, please visit http://www.harrisinteractive.com.
Harris Interactive
Visit our pharmacy / pharmacist section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/136681.php>
APA
http://www.medicalnewstoday.com/releases/136681.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Benefits Of Generic Medications
posted by Dan on 26 Jan 2009 at 5:13 amMore now than in the past, generic medications have been encouraged and selected by prescribers at a much higher rate due to the problem of the high cost of branded meds that many find unfair and unreasonable. Presently, it is believed that over 60 percent of prescriptions written in the United States are now for generic medications.
Branded meds are still prescribed often, though, mainly due to samples of such meds provided at a doctor’s office from the sales reps who promote these meds. Generics typically are not sampled due to lack of funds compared with branded pharmaceutical companies. Yet generics cost a small fraction, such as a third of the cost of branded medications in certain cases, and yet are therapeutically equivalent. Yet not all branded meds have a generic formulation due to patent exclusivity and therefore cannot be produced until the expiration of this patent of the branded med.
Considering over 130 million in the U.S. take prescribed medications every month. Nearly 4 billion prescriptions filled every year, cost savings is rather important. Also, over 125 thousand in the U.S. die every year from reactions or mistakes from taking pharmaceuticals. This pharmaceutical industry makes about 3 billion dollars every year in the United States, and this annual amount increases over ten percent every year. Yet generic medications are about two thirds of this total pharmaceutical market with the drugs included in this market, however, while most prescriptions are for generic medications, this still is less than 15 percent of the total money spent on prescription drugs. About 75 percent of the newly approved drugs by the FDA are similar in efficacy as drugs that already exist in this market. Finally, about half of all newly approved prescription drugs have had serious side effects soon after they have been approved, so newer is clearly not always better, of course.
Most recently, certain managed health and prescription providers have been actually paying doctors to initiate if not switch their patients to generic medications, if possible. This may be due to a reaction caused by branded pharmaceutical companies offering similar inducements, yet the companies paying doctors is remarkably legal, and therefore allowed to occur. Yet I find this process inappropriate and unethical in regards to patient health, as their objective is one of a profit motive more than actual cost saving for the patient.
Not long ago, generic meds were not prescribed that often, or produced to a great degree, because of the cost of bringing such a med to the market, which at the time required the same clinical trial protocols as branded meds. Fast forward to 1984, as this is when the Hatch-Waxman Act was introduced, and this Act only required generic meds to demonstrate bioequivalence to the branded med that they desire to reverse engineer, and nothing else included in the approval process that is required by branded medications to be completely developed and approved by the FDA. This reduced cost of generic manufacturing and approval allowed for more of these meds to saturate the pharmaceutical market, and doctors started prescribing more generic meds as a result.
Branded pharmaceutical companies were not pleased in large part with this new act, so they devised schemes to extent the patents of their branded meds through such tactics as reformulation, which is called evergreening, of their meds, which allows for them to continue the lifespan of their branded medication. Also, such tactics implemented by pharmaceuticals, such as frivolous patent infringement lawsuits, which delays generic availability for a longer period. Also, branded pharmaceutical companies have been known to actually pay generic manufacturers to not release the equivalent of a branded medication.
Yet pharmacies support generic use, as they make more money off of generic prescriptions they fill for others as compared with branded drugs. So delays will not prevent the utilization of generics, overall. Generics seem to remain a concern to branded companies in spite of their efforts of avoiding their access, as branded companies have progressively started producing their own generic meds along with their branded ones due to the increased use of generics, or have acquired generic pharmaceutical companies entirely.
Also, other reasons for increased generic prescribing may be due to the awareness and clinical experience of the previous branded med that has been replicated by the generic medication. Newer drugs at times are not a desirable choice of treatment for patients because of lack of confidence- with possibly safety being the main concern with some prescribers. So the familiarity of a generic equivalent of a known med creates a more reassuring choice for the prescriber. Available generics are listed in what is called an orange book. It should be available to all health care providers for their access. And some studies show that generics are as effective compared with branded medications for particular disease states. The ALLHAT trial showed this, with generic diuretics showed equivalence if not superiority over the branded medications it was compared with during this 4 year trial funded mostly by the NIH.
Most encouraging for even greater use of generic meds is that at least one company has created vending devices for doctor’s offices for dispensing both generic and over the counter meds. This may discourage the use of branded equivalent meds at a greater amount with generic samples available as well as the branded meds. In addition, and in some cases, doctors can order generic samples from the manufacturers. I consider this device rather innovative.
Yet some doctors insist that you get what you pay for, so they are convinced that branded meds are always more efficacious and tolerable than generic meds. This misconception is a fallacy, since both forms are identical from a bioequivalence and bioavailability paradigm, as required for approval. I’m sure it’s possible others have encouraged such doctors to take such a stance void of fact and reason. Yet there may be some truth to decreased efficacy of generic meds over their branded equivalents.
If one considers the health care crisis in our country and the over-priced treatment methods in our health care system, such as with branded pharmaceuticals, generic medications should be considered when clinically appropriate for the benefit of those seeking restoration of their health. It would beneficial for patients to become aware of this pharmaceutical system and request generics when being prescribed a med by their health care provider. In other words, they should question authority figures such as doctors are perceived to be, as patients definitely have a right to acquire knowledge and use this for their benefit with situations as their choices for treatment options, as this will be for their financial benefits while improving their well-being with generic medications- an ideal way to reduce health care costs and improve compliance with their meds because generics are an affordable asset to public health.
“What good fortune for those in power that the people do not think.” --- Adolph Hitler
Dan Abshear
Authors note: What has been composed above is based upon information and belief
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
